Dante Labs renewed its commitment to the annual Black Friday special offer so that more people will get access to affordable whole genome sequencing worldwide

This new approach to genomic data will provide new insights to individuals for diseases such as cancers, epilepsy, diabetes, Alzheimer's, Parkinson's disease and other rare diseases. People in all countries will be able to benefit from Dante Labs AI.

Dante Labs launched Dante Labs Business, a new portal tailored for Healthcare Professionals and Researchers that combines the great genetics expertise of Dante Labs with the tailored needs of the private healthcare sector, academia and research.

Dante Labs introduced 30x long reads whole genome sequencing based on Oxford Nanopore technology. This is the first long reads whole genome available commercially worldwide. Sequencing will be performed at Dante Labs' new highly automated, certified third-generation sequencing center in L'Aquila, Italy.

Dante Labs takes the first step of its ambitious project to integrate high coverage genome sequencing in clinical care in clinics and hospitals.

1,000 patients will receive free whole genome sequencing and interpretation, including personalized reports, thanks to Epilepsy Awareness Day at Disneyland, in a push to advance new research and gene therapies